Integrated Diagnostics Holdings plc (IDGXF)
OTCMKTS · Delayed Price · Currency is USD
0.4854
0.00 (0.00%)
At close: Aug 26, 2025
IDGXF Market Cap
IDGXF has a market cap or net worth of $276.71 million as of September 5, 2025. Its market cap has increased by 18.40% in one year.
Market Cap
276.71M
Enterprise Value
283.09M
Revenue
136.41M
Ranking
n/a
PE Ratio
12.50
Stock Price
$0.49
Market Cap Chart
Since May 6, 2015, IDGXF's market cap has decreased from 840.00M to 276.71M, a decrease of -67.06%. That is a compound annual growth rate of -10.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 276.71M | 8.92% |
| Dec 31, 2024 | 254.04M | 19.27% |
| Dec 29, 2023 | 213.00M | -44.01% |
| Dec 30, 2022 | 380.40M | -50.66% |
| Dec 31, 2021 | 771.00M | 16.82% |
| Dec 31, 2020 | 660.00M | 10.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 840.66M |
| Elite Pharmaceuticals | 757.64M |
| Tian'an Technology Group | 660.01M |
| Glass House Brands | 561.06M |
| Northwest Biotherapeutics | 393.37M |
| CytoDyn | 391.17M |
| American Oncology Network | 361.55M |